Home › Urogenital Cancer › Washington
Urogenital Cancer clinical trials in Washington, DC
6 studies for Urogenital Cancer are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- National Institutes of Health, Bethesda · 7 mi away
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Gender Related Coping and Survivorship for Genitourinary Cancers
RecruitingObservational study
- Sibley Memorial Hospital, Washington D.C.
Urogenital Cancer trials in other cities
- Houston, TX6 studies
- Columbus, OH5 studies
- Nashville, TN5 studies
- Durham, NC4 studies
- St. Louis, MO3 studies
- Cedar Rapids, IA3 studies
- Ann Arbor, MI3 studies
- Atlanta, GA3 studies
- Orange, CA3 studies
- Los Angeles, CA3 studies
- Omaha, NE3 studies
- Boston, MA3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.